MedTrace Logo

Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules

NCT03392402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 599

Last updated 2021-09-05

No results posted yet for this study

Summary

This study evaluates the usefulness of molecular classifier to aid the diagnosis of malignancy in the material obtained by fine-needle aspiration biopsy (FNAB) of thyroid nodule. All participants will undergo FNAB with routine cytological assessment and molecular testing. Patients will undergo surgery or be followed-up, according to the clinical guidelines. The diagnostic power of combined molecular/clinical classifier will be compared to prediction based on clinical features only, by investigators blinded to the final diagnosis of surgical assessment.

Conditions

Sponsors & Collaborators

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Principal Investigators

  • Barbara Jarzab, MD, PhD · Maria Sklodowska-Curie National Research Institute of Oncology

  • Rafal Tarnawski, MD, PhD · Maria Sklodowska-Curie National Research Institute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-03-31
Completion
2020-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03392402 on ClinicalTrials.gov